Sales slide for krill player amid plant expansion

By staff reporter

- Last updated on GMT

Related tags Clinical trial Pharmacology

Leading krill player, Neptune Technologies & Bioressources, has seen sales slip by eight per cent to $2.88 million, from $3.13m in Q1 in 2008, but has put in place plant expansion and continued with acquisitions.

The Canadian company recorded a net loss of $1.41m compared to $1.28m over the same period of comparison, as expansion costs were factored into the equation, but turned in a positive earnings before interest, tax, depreciation, amortization (EBITDA) of $36,000.

The company said results were affected by the temporary closure of its Quebec plant as equipment upgrades were put in place and other facilities tweaked. This work being completed, Neptune’s capacity for krill-sourced ingredients is up to 90,000kg per annum.

Corporate expansion meant EBITDA dropped to $284,000 after research and development work carried out at sub-divisions, Acasti Pharma and NeuroBioPharm, drew funding from the parent over the three-month period ended May 31.

Neptune said Acasti has completed work toward an IND and completed animal pharmacology and toxicology studies, pharmacokinetics, mechanism of action, GMP chemistry, manufacturing, control data and proposed clinical protocols information.

A clinical trial application in Canada was underway.

Krill are tiny shrimp gaining attention as a rich source of omega-3, as well as other nutrients.

There are about 85 species of the deepwater marine planktonic crustacean, or deepwater shrimp, which the planet's most abundant animal biomass and which when captured and converted to oil, pack 48 times the antioxidant punch of standard fish oils, according to ORAC antioxidant scales.

Neptune’s products are available in North America, Europe, Asia and Australia.

Related news

Show more

Related products

show more

How to soothe pet with natural ingredients

How to soothe pet with natural ingredients

Ingredia SA | 06-Mar-2023 | Product Presentation

Stress rises for your pet, which may lead to destructive behaviors, barking, accidents in the house, skin, or gastrointestinal problems.

Magtein Application Data for Product Development

Magtein Application Data for Product Development

AIDP, Inc | 01-Mar-2023 | Application Note

Brain health and mental wellness are intertwined. Brain health products are no longer just for memory and focus and have expanded into related health segments...

Related suppliers

Follow us


View more